Why the FDA’s Involvement in AI is a Good Thing

The use of artificial intelligence (AI) in healthcare, particularly radiology, continues to expand, but not without skepticism from clinicians and healthcare leaders. One way for a company to earn trust for its AI solutions is through the rigorous FDA approval process. Qure.ai is proof that it works.Dr. Samir Shah, Chief Medical Officer at Qure.ai, recently agreed to sit down with Healthcare IT Today to discuss the company’s focus on seeking FDA approval for its AI solutions. To date, they have an industry-leading 18 FDA-cleared AI algorithms. Having that level of approval has helped the company earn trust.Dr. Shah explained that FDA approvals are a critical step in ensuring AI tools meet high standards for safety and effectiveness. “Without this regulation, it could be like the wild west,” Shah noted.

Medigy Insights

The adoption of AI in healthcare, particularly radiology, faces skepticism from clinicians and leaders. Qure.ai addresses this by securing FDA approval, with 18 FDA-cleared AI algorithms to date, building trust in its solutions. Dr. Samir Shah, Chief Medical Officer at Qure.ai, highlights the importance of FDA regulation to ensure safety and effectiveness, preventing unregulated AI use. He emphasizes that rigorous FDA standards provide validation and confidence, fostering broader acceptance of AI in clinical practice.

Continue reading at healthcareittoday.com

Make faster decisions with community advice

Deploy this technology today

Redefining Healthcare: Exoskeleton Technology For Patient Handling And Surgical Support

There is a developing trend of occupational exoskeletons finding a home in medical facilities. Taking care of others is neither cheap nor easy. Nurses and caregivers who engage in patient transfer and …

Posted Jan 25, 2025